multiple sclerosis
→
ReceivesAction
→
diagnosed
|
0.56
|
|
multiple sclerosis
→
ReceivesAction
→
characterized by demyelination
|
0.37
|
|
multiple sclerosis
→
ReceivesAction
→
difficult to diagnose
|
0.36
|
|
multiple sclerosis
→
ReceivesAction
→
suspected
|
0.36
|
|
multiple sclerosis
→
ReceivesAction
→
identified by a genomewide study
|
0.33
|
|
multiple sclerosis
→
ReceivesAction
→
treated
|
0.33
|
|
multiple sclerosis
→
ReceivesAction
→
categorized by bouts of activity
|
0.30
|
|
multiple sclerosis
→
ReceivesAction
→
treated with fingolimod
|
0.28
|
|
multiple sclerosis
→
ReceivesAction
→
characterized by muscle weakness
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
common in canada
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
common in europe
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
incubated with blue bars
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
reversed in mouse models
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
treated with alemtuzumab
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
treated with interferon
|
0.25
|
|
multiple sclerosis
→
ReceivesAction
→
determined by genetic
|
0.24
|
|
multiple sclerosis
→
ReceivesAction
→
diagnosed in child
|
0.21
|
|
multiple sclerosis
→
ReceivesAction
→
marked by periods of remission …
|
0.19
|
|
multiple sclerosis
→
ReceivesAction
→
characterized by axonal loss
|
0.16
|
|
multiple sclerosis
→
ReceivesAction
→
linked to diet
|
0.16
|
|